Literature DB >> 33727914

Impact of Hepatoma-Derived Growth Factor Blockade on Resiniferatoxin-Induced Neuropathy.

Chieh-Hsin Wu1,2, Ming-Kung Wu3, Chun-Ching Lu4,5, Hung-Pei Tsai1, Ying-Yi Lu6,7,8, Chih-Lung Lin1,2.   

Abstract

Resiniferatoxin is an ultrapotent capsaicin analog that mediates nociceptive processing; treatment with resiniferatoxin can cause an inflammatory response and, ultimately, neuropathic pain. Hepatoma-derived growth factor, a growth factor related to normal development, is associated with neurotransmitters surrounding neurons and glial cells. Therefore, the study aims to investigate how blocking hepatoma-derived growth factor affects the inflammatory response in neuropathic pain. Serum hepatoma-derived growth factor protein expression was measured via ELISA. Resiniferatoxin was administrated intraperitoneally to induce neuropathic pain in 36 male Sprague-Dawley rats which were divided into three groups (resiniferatoxin+recombinant hepatoma-derived growth factor antibody group, resiniferatoxin group, and control group) (n = 12/group). The mechanical threshold response was tested with calibration forceps. Cell apoptosis was measured by TUNEL assay. Immunofluorescence staining was performed to detect apoptosis of neuron cells and proliferation of astrocytes in the spinal cord dorsal horn. RT-PCR technique and western blot were used to measure detect inflammatory factors and protein expressions. Serum hepatoma-derived growth factor protein expression was higher in the patients with sciatica compared to controls. In resiniferatoxin-group rats, protein expression of hepatoma-derived growth factor was higher than controls. Blocking hepatoma-derived growth factor improved the mechanical threshold response in rats. In dorsal root ganglion, blocking hepatoma-derived growth factor inhibited inflammatory cytokines. In the spinal cord dorsal horn, blocking hepatoma-derived growth factor inhibited proliferation of astrocyte, apoptosis of neuron cells, and attenuated expressions of pain-associated proteins. The experiment showed that blocking hepatoma-derived growth factor can prevent neuropathic pain and may be a useful alternative to conventional analgesics.
Copyright © 2021 Chieh-Hsin Wu et al.

Entities:  

Year:  2021        PMID: 33727914      PMCID: PMC7937473          DOI: 10.1155/2021/8854461

Source DB:  PubMed          Journal:  Neural Plast        ISSN: 1687-5443            Impact factor:   3.599


  76 in total

1.  The time course of CO2 laser-evoked responses and of skin nerve fibre markers after topical capsaicin in human volunteers.

Authors:  Michael Ragé; Nathalie Van Acker; Paul Facer; Ravikiran Shenoy; Michiel W M Knaapen; Maarten Timmers; Johannes Streffer; Praveen Anand; Theo Meert; Leon Plaghki
Journal:  Clin Neurophysiol       Date:  2010-03-26       Impact factor: 3.708

2.  Resiniferatoxin induces paradoxical changes in thermal and mechanical sensitivities in rats: mechanism of action.

Authors:  Hui-Lin Pan; Ghous M Khan; Kevin D Alloway; Shao-Rui Chen
Journal:  J Neurosci       Date:  2003-04-01       Impact factor: 6.167

3.  Identification, cloning, and developmental expression of hepatoma-derived growth factor in the developing rat heart.

Authors:  A D Everett
Journal:  Dev Dyn       Date:  2001-11       Impact factor: 3.780

4.  Tumor necrosis factor-α mediated pain hypersensitivity through Ret receptor in resiniferatoxin neuropathy.

Authors:  Shui-Chin Lu; Ying-Shuang Chang; Hung-Wei Kan; Yu-Lin Hsieh
Journal:  Kaohsiung J Med Sci       Date:  2018-09       Impact factor: 2.744

5.  Role of spinal NMDA receptors, protein kinase C and nitric oxide synthase in the hyperalgesia induced by magnesium deficiency in rats.

Authors:  S Begon; G Pickering; A Eschalier; A Mazur; Y Rayssiguier; C Dubray
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

Review 6.  TNF-alpha and neuropathic pain--a review.

Authors:  Lawrence Leung; Catherine M Cahill
Journal:  J Neuroinflammation       Date:  2010-04-16       Impact factor: 8.322

7.  Phosphatidylinositol 3-kinase is a key mediator of central sensitization in painful inflammatory conditions.

Authors:  Sophie Pezet; Fabien Marchand; Richard D'Mello; John Grist; Anna K Clark; Marzia Malcangio; Anthony H Dickenson; Robert J Williams; Stephen B McMahon
Journal:  J Neurosci       Date:  2008-04-16       Impact factor: 6.167

8.  A new promising simultaneous approach for attenuating type II diabetes mellitus induced neuropathic pain in rats: iNOS inhibition and neuroregeneration.

Authors:  Abhilasha Ahlawat; Saurabh Sharma
Journal:  Eur J Pharmacol       Date:  2017-11-14       Impact factor: 4.432

Review 9.  Role of TNF-alpha during central sensitization in preclinical studies.

Authors:  Pablo Andrade; Veerle Visser-Vandewalle; Carolin Hoffmann; Harry W M Steinbusch; Marc A Daemen; Govert Hoogland
Journal:  Neurol Sci       Date:  2011-05-11       Impact factor: 3.307

10.  The macrophage response to central and peripheral nerve injury. A possible role for macrophages in regeneration.

Authors:  V H Perry; M C Brown; S Gordon
Journal:  J Exp Med       Date:  1987-04-01       Impact factor: 14.307

View more
  2 in total

1.  The Contribution of TSLP Activation to Hyperalgesia in Dorsal Root Ganglia Neurons of a Rat.

Authors:  Chun-Ching Lu; Ying-Yi Lu; Hung-Pei Tsai; Chieh-Hsin Wu
Journal:  Int J Mol Sci       Date:  2022-02-11       Impact factor: 5.923

2.  Increased Expression of Thymic Stromal Lymphopoietin in Chronic Constriction Injury of Rat Nerve.

Authors:  Chieh-Hsin Wu; Chun-Ching Lu; Chao-Lan Huang; Ming-Kung Wu; Ying-Yi Lu
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.